Skip To Main Content
Rashmi Patel on Muck Rack

Rashmi Patel

New Jersey
As seen in: Color Research & Application, Nature, BuzzFeed, Cambridge University Press & Assessment, BMJ Open, Taylor & Francis Online, Mint, Cell Press, Scroll.in, King's College London and
Writer. Artist. She/her. New Jersey. Melbourne. Bangalore. Ahmedabad. Stories and Articles in @BLReview @picadorbooks @livemint @scroll_in & others.

Get in touch with Rashmi

Contact Rashmi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Real-world treatment patterns, healthcare resource utilization and economic burden in U.S. adults with schizophrenia with and without tardive dyskinesia

|
By Rashmi Patel, Doyoung Kim, Weihua Gao, Ayaan Khan, Matthew Sidovar, Kristin K. Gillard, Talynn Scott
| Nature Verified
Abstract Tardive dyskinesia (TD) is a persistent, iatrogenic movement disorder arising from long-term use of dopamine receptor antagonists, particularly antipsychotics; however, its clinical and economic impact among adults with schizophrenia remains poorly characterized in real-world settings.
Open in Who Shared Issue with article?

‘The Unrepentant’: These Short stories looking at Malaysia’s past feel intimate, yet startlingly new

|
By Rashmi Patel
| Scroll.in Verified
If you’ve ever wondered what histories slip through the cracks of mainstream publishing,The Unrepentant by Sharmini Aphrodite is a good answer. These fourteen stories, published by New York City-based indie press Gaudy Boy, open a window into Malaysia’s past that feels both intimate and startlingly new.
Open in Who Shared Issue with article?

Development and validation of a precision treatment rules for first-line antipsychotic recommendations in first episode psychosis jointly incorporating effectiveness, side effects and patient preferences

|
By Kamil Krakowski, Dominic Oliver, Maite Arribas, Yanakan Logeswaran, Andrea De Micheli, Rashmi Patel, Daniel Stahl, Paolo Fusar-Poli
| Nature Verified
Abstract Selecting first-line antipsychotic medication for first episode of psychosis patients is a very challenging task requiring the clinicians to empirically weight multiple criteria. Precision treatment rules developed using health records offer a pragmatic approach to support clinicians’ treatment selection, however, they don’t incorporate side effects and patient preferences.
Open in Who Shared Issue with article?
See all 38 licensed articles (39 Total)